These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016. Zhang F; Li Y; Lv Y; Zheng B; Xue F J Glob Antimicrob Resist; 2019 Jun; 17():276-282. PubMed ID: 30611932 [TBL] [Abstract][Full Text] [Related]
5. Drug repositioning: auranofin as a prospective antimicrobial agent for the treatment of severe staphylococcal infections. Cassetta MI; Marzo T; Fallani S; Novelli A; Messori L Biometals; 2014 Aug; 27(4):787-91. PubMed ID: 24820140 [TBL] [Abstract][Full Text] [Related]
6. Antiseptic Resistance in Methicillin Sensitive and Methicillin Resistant Staphylococcus aureus Isolates from Some Major Hospitals, Iran. Hasanvand A; Ghafourian S; Taherikalani M; Jalilian FA; Sadeghifard N; Pakzad I Recent Pat Antiinfect Drug Discov; 2015; 10(2):105-12. PubMed ID: 26100979 [TBL] [Abstract][Full Text] [Related]
7. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2018. Coombs GW; Daley DA; Mowlaboccus S; Lee YT; Pang S; Commun Dis Intell (2018); 2020 Mar; 44():. PubMed ID: 32178604 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial activity of gallium maltolate against Staphylococcus aureus and methicillin-resistant S. aureus and Staphylococcus pseudintermedius: An in vitro study. Arnold CE; Bordin A; Lawhon SD; Libal MC; Bernstein LR; Cohen ND Vet Microbiol; 2012 Mar; 155(2-4):389-94. PubMed ID: 21963417 [TBL] [Abstract][Full Text] [Related]
9. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal. Adhikari RP; Shrestha S; Barakoti A; Amatya R BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin. Fuchs BB; RajaMuthiah R; Souza AC; Eatemadpour S; Rossoni RD; Santos DA; Junqueira JC; Rice LB; Mylonakis E Future Med Chem; 2016; 8(2):117-32. PubMed ID: 26808006 [TBL] [Abstract][Full Text] [Related]
11. Repurposing auranofin for the treatment of cutaneous staphylococcal infections. Thangamani S; Mohammad H; Abushahba MF; Sobreira TJ; Seleem MN Int J Antimicrob Agents; 2016 Mar; 47(3):195-201. PubMed ID: 26895605 [TBL] [Abstract][Full Text] [Related]
12. Antimicrobial susceptibility pattern of Staphylococcus aureus isolates from clinical specimens at Kenyatta National Hospital. Gitau W; Masika M; Musyoki M; Museve B; Mutwiri T BMC Res Notes; 2018 Apr; 11(1):226. PubMed ID: 29615129 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of antibiotic resistance pattern in clinical isolates of Staphylococcus aureus. Hanif E; Hassan SA Pak J Pharm Sci; 2019 May; 32(3 (Supplementary)):1219-1223. PubMed ID: 31303594 [TBL] [Abstract][Full Text] [Related]
14. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples. Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895 [TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea. Nam HM; Lee AL; Jung SC; Kim MN; Jang GC; Wee SH; Lim SK Foodborne Pathog Dis; 2011 Feb; 8(2):231-8. PubMed ID: 21034263 [TBL] [Abstract][Full Text] [Related]
16. Antibiofilm efficacy of the gold compound auranofin on dual species biofilms of Staphylococcus aureus and Candida sp. She P; Liu Y; Wang Y; Tan F; Luo Z; Wu Y J Appl Microbiol; 2020 Jan; 128(1):88-101. PubMed ID: 31509623 [TBL] [Abstract][Full Text] [Related]
17. Streptomyces sp. 6E3 antimicrobial activity isolated from mineral concentrate. Ampuero A; Rojas R; Ruiz C; Hurtado J Rev Peru Med Exp Salud Publica; 2020; 37(1):110-114. PubMed ID: 32520172 [TBL] [Abstract][Full Text] [Related]
18. Antimicrobial Resistance and Molecular Characteristics of Nasal Staphylococcus aureus Isolates From Newly Admitted Inpatients. Chen X; Sun K; Dong D; Luo Q; Peng Y; Chen F Ann Lab Med; 2016 May; 36(3):250-4. PubMed ID: 26915614 [TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model. Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524 [TBL] [Abstract][Full Text] [Related]
20. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan. Naimi HM; Rasekh H; Noori AZ; Bahaduri MA BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]